We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » 3D-Bioprinted Tissue Implant Reconstructs Human Ear in Clinical Trial
3D-Bioprinted Tissue Implant Reconstructs Human Ear in Clinical Trial
3DBio Therapeutics, a New York-based regenerative medicine company, and the Microtia-Congenital Ear Deformity Institute in San Antonio, Texas, have partnered to reconstruct a human ear using the company’s AuriNovo 3D-bioprinted implant.
To View This Article:
Login
Subscribe To Device Daily Bulletin Premium
Device Daily Bulletin Premium Subscription
Upgrade to Device Daily Bulletin Premium to get all the articles in the free publication PLUS more in-depth stories on regulatory and industry developments, FDA inspection and enforcement activities and analysis of market trends. It makes sense of everything successful devicemakers must know and do, delivering the news, analysis and interpretation of industry changes you need to stay compliant and thrive. And it’s combined with timely content from FDAnews management reports and webinars. Learn more